Actos Bladder Cancer Referring AttorneysFrequently Asked Questions about Actos Bladder CancerUpdates on Actos Bladder CancerHome of Actos Bladder Cancer Information

ACTOS ARTICLES AND UPDATES

UPDATES


ACTOS CASE UPDATE - August 14, 2013

Since our last update, several big developments have occurred in the nationwide Actos litigation. The first Actos lawsuit was tried outside of the MDL in Los Angeles, California, where the plaintiff, like all of our own clients, alleged that Takeda failed to warn him of the risks associated with Actos. This lawsuit ended with a verdict for the plaintiff, but the California judge in that case overturned the verdict on a legal technicality. The California case is an example of why it can be dangerous to file cases outside of a consolidated group, such as the MDL or Illinois state court. However, even though the plaintiff lost that particular case, we see it as a win for our clients, and the remaining plaintiffs, as we can easily spot and avoid the issues that arose during that trial.

The bellwether trial cases mentioned in our last update have now been officially set for January 27, 2014 and April 14, 2014. Hopefully at the conclusion of these trials, Takeda will take action towards resolving the remaining cases throughout the country. For now, most of our clients are in the process of completing the court ordered Plaintiff Fact Sheets that include a brief personal and medical history. This is the next step in successfully bringing an Actos claim, and one that is essential. So if you are a client and have not completed a Plaintiff Fact Sheet, please be in contact with our office immediately.

Posted August 14, 2013
By Buck Daniel


JUDGE SETS TRIAL DATES IN ACTOS MDL

A scheduling order issued by Judge Rebecca Doherty has set the first Actos lawsuit trial to begin on November 3, 2014 with a second trial scheduled for July 8, 2015. The judge also stated in the scheduling order that the attorneys for plaintiffs and defendants must select these potential trial cases by June 3, 2013 so that a definitive order and roster of parties can be finalized. The parties will have until September 30, 2013 to complete core discovery in these cases.

Judge Doherty stated in the scheduling order that even though these court cases are more than two years from now, the large scope of the litigation, the number of plaintiffs who have already filed Actos bladder cancer claims and the number of additional plaintiffs who could join the litigation that these deadlines need to be met in order for the case to avoid potentially long delays.

Posted November 7, 2012
by Buck Daniel



TWELVE ACTOS LAWSUITS FILED IN CALIFORNIA STATE COURT, LOS ANGELES COUNTY

A consolidated complaint was filed by 12 plaintiffs, who claim to have been diagnosed with bladder cancer as a result of using Actos, on August 14, 2012. Specifically, the court documents allege that the defendants, Takeda Pharmaceuticals, should have known about the risks of developing bladder cancer after using Actos. The filing further alleges that the defendants were specifically aware of these dangers prior to seeking approval to market Actos from the FDA in 1999. Finally, the court documents allege that Takeda continued to conceal this knowledge and willfully put the lives of the plaintiffs, as well as the general population, at risk by way of warnings on the product that were vague and inadequate.

Posted November 7, 2012
by Buck Daniel


FURTHER EVIDENCE ACTOS LINKED TO BLADDER CANCER

May 31, 2012
In a linked study ... Azoulay and colleagues found that more than two years daily exposure to pioglitazone doubled the risk of bladder cancer.

Read the full .PDF article on further evidence of bladder cancer here.

Posted June 8, 2012
By Buck Daniel
The Nations Law Firm

Top of Page


CREATION OF AN ACTOS MDL

October 26, 2011
It will soon be decided whether or not the Actos cases, which are being filed in courts across the country, would be more effectively handled as a multi-district litigation. The United States Judicial Panel on Multi-District Litigation will hold a hearing on December 1, 2011 to discuss this matter. If the Panel decides to create an Actos MDL, the next decision will be in which court and before which judge the MDL will be placed. Thousands of lawsuits against the Actos manufacturer Takeda Pharmaceuticals are expected to be filed by consumers who developed bladder cancer as a result of taking this popular diabetic medication. Click here to see the Notice of Hearing.

Cindy L. Nations
The Nations Law Firm

Top of Page

ARTICLES


NEW ADVICE ON RISK OF BLADDER CANCER WITH THE ANTI-DIABETIC DRUG PIOGLITAZONE

July 22, 2011
New Advice on Risk of Bladder Cancer
The review found that there is a small increased risk of bladder cancer associate with pioglitazone use. It is not clear if the risk.

Read the full .PDF article on Advice on Risk of Bladder Cancer from MHRA here.

Top of Page


FDA JOINS FRANCE AND GERMANY WITH ACTOS BLADDER CANCER WARNING BUT STOPS SHORT OF RECALL

In preclinical in vivo studies, bladder cancer was observed in male rats receiving clinical equivalent doses of pioglitazone.  In addition, two clinical studies of Actos (the PROactive study, detailed in The Lancet - Oncology and a liver safety study) showed a high percentage of bladder cancer cases in patients taking Actos.

Read the full .PDF article on FDA joining France and Germany for cancer warnings here

URL: http://drsamgirgis.com/2011/06/15/fda-joins-france-and-germany-with-actos-bladder-cancer-warning-but-stops-short-of-recall/#axzz1Xl7SY6Fq

Read the Lancet article here... http://www.thelancet.com/journals/lancet/article/PIIS0140673605675289/abstract

Top of Page


DEPARTMENT OF HEALTH AND HUMAN SERVICES - SUBMITTAL OF ACTOS / ACTOSPLUS MET FOR LABEL CHANGES

Letter from Dept. of Health & Human Services to Takeda Global Research & Development Center, Inc. concerning label changes to reflect reports that the drug Actos can cause bladder cancer. Read the full letter here...

Top of Page